PepperLime Health Acquisition Overview
PepperLime Health Acquisition (PEPL) has a ROE of 91.4%, above the sector sector average of 11.73%.
Get informed when a big investor buys or sells
+ Follow91.40%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for PEPL is 91.4%. That is above the sector sector average of 11.73%. Investors often review this figure alongside PepperLime Health Acquisition's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, PEPL currently prints 91.4% for ROE, while the sector average sits near 11.73%. That is roughly 678.9% above the sector mean. Large gaps often invite a closer look at PepperLime Health Acquisition's growth, margins, and balance sheet.
Return on Equity shows how effectively PepperLime Health Acquisition converts resources into returns. At 91.4%, PEPL may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PEPL's ROE (91.4%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
